In order to achieve its investment objective

The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

Find out more about us

logo-orbimed-black.svg

Investor Update Webinar -

March 2024

View more videos

Factsheets

View factsheet archive

How to invest

The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.

Find out more

£344.1m

Our Net Asset Value*

37.9%

Five year share price (total return)*

38.6%

Five year Net Asset Value per share (total return)*

 

Source: Frostrow Capital LLP

*As at 30 April 2024